Karyopharm Therapeutics Operating Expenses 2011-2026 | KPTI

Annual Operating Expenses Karyopharm Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
237 M	265 M	276 M	299 M	308 M	280 M	228 M	210 M	132 M	111 M	119 M	76.1 M	34.3 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
308 M	34.3 M	198 M

Quarterly Operating Expenses Karyopharm Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
61.8 M	59.3 M	62.3 M	63.3 M	-	65.1 M	70.9 M	66.9 M	-	67.3 M	67.2 M	69.6 M	-	67 M	82.6 M	82.3 M	-	81.5 M	71.6 M	75.6 M	-	68.4 M	73.8 M	65.5 M	-	52.6 M	51.2 M	65.1 M	57.7 M	49.4 M	54.2 M	48.9 M	41 M	31.1 M	29.8 M	30.3 M	27.2 M	25.8 M	30.5 M	27.3 M	29.3 M	30.7 M	33.2 M	26.2 M	26 M	19.8 M	16.5 M	13.9 M	12.2 M	9.32 M	7 M	5.84 M	4.27 M	3.67 M	4.57 M	4.02 M	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
82.6 M	3.67 M	43.8 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Alpine Immune Sciences ALPN	103 M	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	55.7 M	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
CRISPR Therapeutics AG CRSP	668 M	$ 53.09	2.06 %	$ 4.77 B	Schweiz
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 32.93	1.89 %	$ 2.19 B	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	98.4 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	51.6 M	$ 14.23	-0.49 %	$ 204 M	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Precision BioSciences DTIL	92.5 M	$ 6.5	3.01 %	$ 25 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	15 M	$ 0.62	-1.94 %	$ 28.3 M	Israel
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 26.22	2.14 %	$ 3.34 B	USA
Allena Pharmaceuticals ALNA	10.1 M	-	3.16 %	$ 1.9 M	USA